CUREVO
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines that brings effectiveness, safety, tolerability, and advanced production capabilities to the market. Curevo's lead product, a sub-unit Zoster (Shingles) Vaccine, has completed Phase I (90 subject trial). Results are showing a promising safety profile and the desired immune responses. They are targeting a unique position in the $7B Varicella Zoster Virus vaccine market.
CUREVO
Industry:
Biopharma Biotechnology
Founded:
2018-01-01
Website Url:
http://www.curevovaccine.com
Total Employee:
1+
Status:
Active
Contact:
1(206)492-5722
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Domain Not Resolving Microsoft Exchange Online
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Current Employees Featured
Investors List
Janus Henderson Investors
Janus Henderson Investors investment in Series A - Curevo
E&Investment
E&Investment investment in Series A - Curevo
RA Capital Management
RA Capital Management investment in Series A - Curevo
Green Cross Holding Corp
Green Cross Holding Corp investment in Series A - Curevo
Adjuvant Capital
Adjuvant Capital investment in Series A - Curevo
Official Site Inspections
http://www.curevovaccine.com
- Host name: 192.0.78.148
- IP address: 192.0.78.148
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
